» Articles » PMID: 21303640

Noninvasive Diagnostic Devices for Diabetes Through Measuring Tear Glucose

Overview
Specialty Endocrinology
Date 2011 Feb 10
PMID 21303640
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

This article reviews the development of a noninvasive diagnostic for diabetes by detecting ocular glucose. Early diagnosis and daily management are very important to diabetes patients to ensure a healthy life. Commercial blood glucose sensors have been used since the 1970s. Millions of diabetes patients have to prick their finger for a drop of blood 4-5 times a day to check blood glucose levels--almost 1800 times annually. There is a strong need to have a noninvasive device to help patients to manage the disease easily and painlessly. Instead of detecting the glucose in blood, monitoring the glucose level in other body fluids may provide a feasible approach for noninvasive diagnosis and diabetes control. Tear glucose has been studied for several decades. This article reviews studies on ocular glucose and its monitoring methods. Attempts to continuously monitor the concentration of tear glucose by using contact lens-based sensors are discussed as well as our current development of a nanostructured lens-based sensor for diabetes. This disposable biosensor for the detection of tear glucose may provide an alternative method to help patients manage the disease conveniently.

Citing Articles

A bibliometric and visualization analysis of electrochemical biosensors for early diagnosis of eye diseases.

Zhang F, Xu W, Deng Z, Huang J Front Med (Lausanne). 2025; 11:1487981.

PMID: 39867928 PMC: 11757256. DOI: 10.3389/fmed.2024.1487981.


Sense and Learn: Recent Advances in Wearable Sensing and Machine Learning for Blood Glucose Monitoring and Trend-Detection.

Alhaddad A, Aly H, Gad H, Al-Ali A, Sadasivuni K, Cabibihan J Front Bioeng Biotechnol. 2022; 10:876672.

PMID: 35646863 PMC: 9135106. DOI: 10.3389/fbioe.2022.876672.


Wearable devices for continuous monitoring of biosignals: Challenges and opportunities.

Stuart T, Hanna J, Gutruf P APL Bioeng. 2022; 6(2):021502.

PMID: 35464617 PMC: 9010050. DOI: 10.1063/5.0086935.


Quantification of tear glucose levels and their correlation with blood glucose levels in dogs.

Lee E, Kang S, Shim J, Jeong D, Jeong Y, Ahn J Vet Med Sci. 2022; 8(4):1816-1824.

PMID: 35305285 PMC: 9297779. DOI: 10.1002/vms3.788.


Lab-on-a-Contact Lens: Recent Advances and Future Opportunities in Diagnostics and Therapeutics.

Zhu Y, Li S, Li J, Falcone N, Cui Q, Shah S Adv Mater. 2022; 34(24):e2108389.

PMID: 35130584 PMC: 9233032. DOI: 10.1002/adma.202108389.


References
1.
Ridley F . Safety requirements for acrylic implants. Br J Ophthalmol. 1957; 41(6):359-67. PMC: 509559. DOI: 10.1136/bjo.41.6.359. View

2.
GASSET A, Braverman L, FLEMING M, Arky R, Alter B . Tear glucose detection of hyperglycemia. Am J Ophthalmol. 1968; 65(3):414-20. DOI: 10.1016/0002-9394(68)93093-6. View

3.
Bjerrum K, Prause J . Collection and concentration of tear proteins studied by SDS gel electrophoresis. Presentation of a new method with special reference to dry eye patients. Graefes Arch Clin Exp Ophthalmol. 1994; 232(7):402-5. DOI: 10.1007/BF00186580. View

4.
Ballerstadt R, Evans C, McNichols R, Gowda A . Concanavalin A for in vivo glucose sensing: a biotoxicity review. Biosens Bioelectron. 2006; 22(2):275-84. DOI: 10.1016/j.bios.2006.01.008. View

5.
Lane J, Krumholz D, Sack R, Morris C . Tear glucose dynamics in diabetes mellitus. Curr Eye Res. 2006; 31(11):895-901. DOI: 10.1080/02713680600976552. View